Okadaic acid

221505282564

78111-17-8

1,7-dioxaspiro[5.5]undec-10-ene-2-propanoicacid, a,5-dihydroxy-a,10-dimethyl-8-[(1r,2e)-1-methyl-3-[(2r,4'ar,5r,6's,8'r,8'as)-octahydro-8'-hydroxy-6'-[(1s,3s)-1-hydroxy-3-[(2s,3r,6s)-3-methyl-1,7-dioxaspiro[5.5]undec-2-yl]butyl]-7'-methylenespiro[furan-2(3h),2'(3'h)-pyrano[3,2-b]pyran]-5-yl]-2-propen-1-yl]-,(ar,2s,5r,6r,8s)- | ocadaic acid | okadaic acid,97% | 1,7-dioxaspiro[5.5]undec-10-ene-2-propanoic acid, a,5-dihydroxy-a,10-dimethyl-8-[1-methyl-3-[octahydro-8'-hydroxy-6'-[1-hydroxy-3-(3-methyl-1,7-dioxaspiro[5.5]undec-2-yl)butyl]-7'-methylenespiro[furan-2(3h),2'(3'h)-pyrano[3,2-b]pyran]-5-yl]-2-propenyl]-,[2'r-[2'a[r*[1r*[2s*(r*),5r*,6r*,8s*],2e]],4'ab,6'b[1s*,3s*(2s*,3r*,6s*)],8'a,8'aa]]- | nsc 677083 | okadaic acid | okadaic acid, 98+% | acanthifolicin, 9,10-deepithio-9,10-didehydro- | 35-demethyl-dtx 1 | okadaic acid, 25 ug* | oa | okadic acid | halochondrine a | spiro[furan-2(3h),2'(3'h)-pyrano[3,2-b]pyran],acanthifolicin deriv. | 1,7-dioxaspiro[5.5]undecane,acanthifolicin deriv. | 1,7-dioxaspiro[5.5]undec-10-ene-2-propanoicacid, a,5-dihydroxy-a,10-dimethyl-8-[(1r,2e)-1-methyl-3-[(2r,4'ar,5r,6's,8'r,8'as)-octahydro-8'-hydroxy-6'-[(1s,3s)-1-hydroxy-3-[(2s,3r,6s)-3-methyl-1,7-dioxaspiro[5.5]undec-2-yl]butyl]-7'-methylenespiro[furan-2(3h),2'(3'h)-pyrano[3,2-b]pyran]-5-yl]-2-propenyl]-,(ar,2s,5r,6r,8s)- (9ci)

C44H68 O13

805.12

1.28 g/cm3

921.6 °C at 760 mmHg

269.4 °C

164-166 °C

DMSO: ≥1 mg/mL

white crystals or powder

A poison by intraperitoneal route. Questionable carcinogen. Mutation data reported. When heated to decomposition it emits acrid smoke and irritating vapors.

6.1(a)

farosymboler:

Europa standard Hazard pictograms, code and definition

23/24/25-38 (R)

3

UN 3462 6.1 / PG 1

AA8227800

-20°C